However, in both subgroups, a marked decrease in the biomarkers NT-proBNP and ST2 and also the body weight could be demonstrated, depicting an overall benefit of positive inotropic therapy for both ICM and DCM. The gene discussed is NPPB; the disease is familial dilated cardiomyopathy.